Höfundar: Kari Arnarson

Implementation of Clinical Mass Spectrometry in Iceland

Discovery of novel early-stage biomarker for breast cancer diagnosis by targeted proteomics

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.